Overview

Immune Suppression Of Infants Treated With Steroids

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.
Details
Lead Sponsor:
Medical College of Wisconsin
Treatments:
Methylprednisolone
Methylprednisolone acetate
Methylprednisolone Hemisuccinate
Prednisolone
Prednisolone acetate
Prednisolone hemisuccinate
Prednisolone phosphate